Opus Genetics IRD Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's shares (diluted)?
- Opus Genetics (IRD) reported shares (diluted) of 86.9M in Q1 2026.
- How has Opus Genetics's shares (diluted) changed year-over-year?
- Opus Genetics's shares (diluted) increased by 156.4% year-over-year, from 33.9M to 86.9M.
- What is the long-term trend for Opus Genetics's shares (diluted)?
- Over 4 years (2021 to 2025), Opus Genetics's shares (diluted) has grown at a 42.2% compound annual growth rate (CAGR), from 56.3M to 230.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.